Prospective Study
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jul 16, 2023; 11(20): 4865-4873
Published online Jul 16, 2023. doi: 10.12998/wjcc.v11.i20.4865
Defining the awareness and attitude of the clinicians through pharmacovigilance in Turkey
Ozlem Celik Aydin, Sonay Aydin, Hakkı Zafer Guney
Ozlem Celik Aydin, Sonay Aydin, Hakkı Zafer Guney, Department of Medical Pharmacology, Gazi University Faculty of Medicine, Ankara 06500, Turkey
Author contributions: Aydin OC and Guney HZ put forward the concept; Aydin OC was responsible for designing; Guney HZ were responsible for supervision; Aydin S, Aydin OC and Guney HZ did the literature search and reviewed the manuscript critically; Aydin S and Aydin OC were responsible for materials and wrote the manuscript; All authors have read and approved the final manuscript.
Institutional review board statement: This cross-sectional analytical investigation was approved by the Gazi University Clinical Research Ethics Committee, No. 25901600-604.01.01-16.
Informed consent statement: The study included everyone who agreed to participate in the survey.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: All data will be shared with the relevant parties upon request atozlemclk_89@hotmail.com.
CONSORT 2010 statement: The authors have read the CONSORT 2010 statement, and the manuscript was prepared and revised according to the CONSORT 2010 statement.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ozlem Celik Aydin, MD, Doctor, Department of Medical Pharmacology, Gazi University Faculty of Medicine, Besevler, Ankara 06500, Turkey. ozlemclk_89@hotmail.com
Received: February 21, 2023
Peer-review started: February 21, 2023
First decision: April 10, 2023
Revised: May 1, 2023
Accepted: June 9, 2023
Article in press: June 9, 2023
Published online: July 16, 2023
Core Tip

Core tip: Pharmacovigilance (PV) is the activities and scientific studies conducted to detect, evaluate, understand or prevent adverse reactions and other drug-related problems. This study define the awareness and experiences of clinicians about PV and adverse drug reactions (ADRs) in Turkey. PV knowledge level of the physicians was not sufficient. The results provide more comprehensive data on PV practices and ADR reporting at a national level.